Viewing Study NCT00466466


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-04-02 @ 6:43 AM
Study NCT ID: NCT00466466
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2007-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small-Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Small-Cell Lung Cancer View
None SCLC View
None Advanced Lung Cancer View
None RAD View
None RAD001 View
None Chemotherapy View
None Cisplatin View
None Etoposide View